A 12-Week Phase III Study to Evaluate the Efficacy and Tolerability of Beclomethasone Dipropionate/Formoterol Single Inhaler HFA 134a-pMDI in Adult Patients With Mild to Moderate Persistent Asthma.
Phase of Trial: Phase III
Latest Information Update: 04 Apr 2017
At a glance
- Drugs Beclometasone; Beclometasone/formoterol
- Indications Asthma
- Focus Therapeutic Use
- Sponsors Chiesi Farmaceutici
- 14 Feb 2012 Actual end date (Sep 2005) added as reported by ClinicalTrials.gov.
- 19 Mar 2009 New trial record